Many revolutionary trends and advances have been witnessed by the pharmaceutical and medical device industries that have dramatically improved the medicines available to patients around the world in the last decade. In just ten years, it was possible to witness the effect of artificial intelligence and big data on the diagnosis and treatment of diseases, and a move towards avoiding life-threatening illnesses rather than medicating them.
In addition, the emergence of the COVID-19 pandemic has surged the demand for pharmaceuticals and medical devices across the globe ranging from ventilation systems, disposable kits, and various medications among more. Various companies have retooled their systems to meet the demand for medical devices. R&D by various pharmaceutical companies has increased across the globe to meet the urgent requirement for the COVID-19 vaccine leading to surging demand for quality control endotoxin and pyrogen testing.
The prosperity and expansion of these companies proportionately raise the need for endotoxin and pyrogen monitoring for the quality management of their products because if endotoxin is present in injectable prescription medications or implantable devices and enters the bloodstream or spinal cord, incidents beginning with septic shock, fever, organ damage and possibly death. Therefore, the rapid growth of pharmaceutical and medical devices is expected to drive market growth.
Access Full Report @ https://www.databridgemarketresearch.com/jp/reports/asia-pacific-endotoxin-and-pyrogen-testing-market
Data Bridge Market Research analyses that the Asia-Pacific Endotoxin and Pyrogen Testing Market is expected to grow with a CAGR of 11.9% in the forecast period from 2023 to 2030, and is expected to reach USD 233,324.10 thousand by 2030.
Key Findings of the Study
Increasing R&D Investments and Drug Approvals May Drive the Market Growth
The industries associated with quality control carry out extensive R&D not only to generate revenue but it often bring results in lives by saving or enhancing a patient's lives by providing sterile or contamination-free parenteral drugs and implantable medical devices. R&D is crucial in all industries including industries dealing with quality control such as endotoxin testing.
The R&D in the endotoxin testing market performs research to provide an efficient testing method with enhanced results to minimize the errors leading to product recall among various industries. Moreover, the devices are developed to meet the regulatory standards of endotoxin testing. Nowadays, companies associated with quality control have increased focus on R&D which has raised the demand for endotoxin testing.
In addition, the promising growth in the product pipeline and increasing drug approval are anticipated to drive market growth. The emergence of COVID-19 has also led to increased clinical trials for the development of vaccines for COVID-19. This has further increased the demand for endotoxin and pyrogen testing products and services.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022 (Customizable to 2015-2020)
|
|
Historic Years
|
2021
|
|
Quantitative Units
|
Revenue in USD Thousand and Pricing in USD
|
|
Segments Covered
|
Product Type (Detection Kits & Reagents, Instruments & Systems, Endotoxin, and Pyrogen Testing Services, Consumables & Accessories), Test Type (Limulus Amoebocyte Lysate (LAL) Test, TAL Tests, Monocyte Activation Test (MAT), Recombinant C (RFC) Assay, and Rabbit Pyrogen Test), Application (Pharmaceutical Manufacturing, Medical Device Manufacturing, Raw Materials Production, and Packaging Manufacture), Method (Gel Clot Endotoxin and Pyrogen Test, Chromogenic Endotoxin and Pyrogen Test, and Turbidimetric Endotoxin and Pyrogen Test), Mode of Purchase (Large Group, Mid and Small Group, and Individual), End Product (Vaccines and/ Or CGT, Biologics, Injectable, and Others), End User (Pharmaceutical Companies, Biotechnology Companies, Biomedical Companies, Medical Device Companies, Contract Research Organization (CRO), Contract Manufacturing Organization (CMO), and Others)
|
|
Countries Covered
|
China, Japan, India, South Korea, Australia, Singapore, New Zealand, Indonesia, Philippines, Thailand, Malaysia, Vietnam, and rest of Asia-Pacific
|
|
Market Players Covered
|
Pall Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), Charles River Laboratories (U.S.), Eurofins Scientific (Luxembourg), and SGS Société Générale de Surveillance SA. (Switzerland) among others.
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis
The Asia-Pacific endotoxin and pyrogen testing market is segmented into seven notable segments based on product type, test type, application, method, mode of purchase, end product, and end user.
- On the basis of product type, the market is segmented into detection kits & reagents, instruments & systems, endotoxin and pyrogen testing services, and consumables & accessories
In 2023, the detection kits & reagents segment is expected to dominate the market.
In 2023, the detection kits & reagents segment is expected to dominate the market with a market share of 62.81% due to the technological advancement to develop efficient kits and reagents for quality control in the healthcare sector.
- On the basis of test type, the market is segmented into limulus amoebocyte lysate (LAL) test, TAL test, monocyte activation test (MAT), rabbit pyrogen test, and recombinant C (RFC) assay.
In 2023, the Limulus Amoebocyte Lysate (LAL) test segment is expected to dominate the market.
In 2023, the Limulus Amoebocyte Lysate (LAL) test segment is expected to dominate the market with a market share of 59.58% due to the increased efficiency and reliability of various consumer and regulatory bodies on the particular test type for endotoxin testing.
- On the basis of application, the market is segmented into pharmaceutical manufacturing, medical device manufacturing, raw materials production, and packaging manufacture. In 2023, the pharmaceutical manufacturing segment is expected to dominate the market with a market share of 39.19%
- On the basis of method, the market is segmented into gel clot endotoxin and Pyrogen test, chromogenic endotoxin and Pyrogen test, and turbidimetric endotoxin and Pyrogen test. In 2023, the gel clot endotoxin and Pyrogen test segment is expected to dominate the market with a market share of 59.55%
- On the basis of mode of purchase, the market is segmented into large group, mid and small group, and individual. In 2023, the large group segment is expected to dominate the market with a market share of 63.64%
- On the basis of end product, the market is segmented into vaccine and/or CGT, biologics, injectable, and others. In 2023, the Vaccines and/ Or CGT segment is expected to dominate the market with a market share of 62.33%
- On the basis of end user, the market is segmented into pharmaceutical companies, biotechnology companies, biomedical companies, medical device companies, Contract Research Organization (CRO), Contract Manufacturing Organization (CMO), and others. In 2023, the pharmaceutical companies segment is expected to dominate the market with a market share of 39.84%
Major Players
Data Bridge Market Research analyzes Pall Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), Charles River Laboratories (U.S.), Eurofins Scientific (Luxembourg), and SGS Société Générale de Surveillance SA. (Switzerland) as the major market players in the market.
Market Developments
- In January 2023, Eurofins Scientific, the global leader in food, environment, pharmaceutical, and cosmetic product testing and a global scientific leader in bioanalytical testing, announces the acquisition of assets to establish a fully-equipped, state-of-the-art laboratory campus in Genome Valley, Hyderabad
- In January 2021, Pall Corporation, a global leader in filtration, separation, and purification, is making significant investments in global production capacity to meet industry demands driven by COVID-19. These investments include additional production capacity at six existing manufacturing facilities in Europe and the United States, as well as a new manufacturing facility in the United States. This helps the organization in developing overall revenue
- In October 2020, Lonza unveiled its latest PyroCell MAT System to detect various pyrogens sensitively and sustainably, without the need for laboratory animals. The product was launched with a full solution with optimized MAT reagents from Sanquin and media and accessories from Lonza. The company's introduction of this new product has boosted its credibility and market demand
- In May 2020, Sanquin Reagents B.V. collaborated with Lonza to commercialize its Monocyte Activation Test (MAT) by providing global access to protect parenteral pharmaceuticals during the production, manufacture, and market release of in vitro pyrogen testing. The company's relationship has expanded its product range of quality management products
- In June 2019, SGS was pleased to announce that they had acquired the remaining 40% interest in Maine Pointe, LLC., after originally acquiring a 60% interest. This will help the organization in developing overall revenue
Regional Analysis
Geographically, the countries covered in the market report are China, Japan, India, South Korea, Australia, Singapore, New Zealand, Indonesia, Philippines, Thailand, Malaysia, Vietnam, and rest of Asia-Pacific.
As per Data Bridge Market Research analysis:
China is the fastest-growing and dominant country in the market during the forecast period 2023 -2030
In 2023, China is expected to dominate the market due to the higher level of investments by various manufacturers and increasing technological advancements in the region. China will continue to dominate the market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. China is estimated to be the fastest-growing country in the market during the forecast period 2023 to 2030 due to the growing adoption of advanced technology and the launch of new products in this region.
For more detailed information about the Asia-Pacific Endotoxin and Pyrogen Testing market report, click here – https://www.databridgemarketresearch.com/jp/reports/asia-pacific-endotoxin-and-pyrogen-testing-market
